Drug Candidates for the Prevention and Treatment of Cardiovascular Diseases

被引：0

作者：

Kadoglou, Nikolaos P. E. ^{[1
]}

机构：

[1] Univ Cyprus, Med Sch, CY-2029 Nicosia, Cyprus

来源：

PHARMACEUTICALS | 2024年 / 17卷 / 04期

关键词：

D O I：

10.3390/ph17040417

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页数：3

共 7 条

[1] The pleiotropic effects of statins in rheumatoid arthritis [J].

Aminifar, Elham ;

Afshari, Haleh Sadat Tavakkol ;

Sathyapalan, Thozhukat ;

Abbasifard, Mitra ;

Sahebkar, Amirhossein .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 2023, 75 (07) :910-920

[2] Optimal use of intravenous landiolol in acute cardiac care [J].

Bezati, Sofia ;

Boultadakis, Antonios ;

Ventoulis, Ioannis ;

Polyzogopoulou, Eftihia ;

Parissis, John T. .

EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2023, 21 (11) :855-866

[3] Does Systemic Anti-Psoriatic Treatment Impact the Risk of Cardiovascular Disease? A Review Over Cardiovascular Imaging Studies [J].

Kaiser, Hannah ;

Naeslund-Koch, Charlotte ;

Kvist-Hansen, Amanda ;

Skov, Lone .

DERMATOLOGY AND THERAPY, 2024, 14 (02) :303-321

[4] Prognostic role of inflammatory cytokines and novel adipokines in acute myocardial infarction: An updated and comprehensive review [J].

Mitsis, Andreas ;

Kadoglou, Nikolaos P. E. ;

Lambadiari, Vaia ;

Alexiou, Sophia ;

Theodoropoulos, Konstantinos C. ;

Avraamides, Panayiotis ;

Kassimis, George .

CYTOKINE, 2022, 153

[5]

Pende A, 2012, CURR PHARM DESIGN, V18, P1011

[6] Use of Sodium-Glucose Cotransporter-2 Inhibitors in Clinical Practice for Heart Failure Prevention and Treatment: Beyond Type 2 Diabetes. A Narrative Review [J].

Rao, Shaline .

ADVANCES IN THERAPY, 2022, 39 (02) :845-861

[7] PCSK9 inhibitors for secondary prevention in patients with cardiovascular diseases: a bayesian network meta-analysis [J].

Wang, Xing ;

Wen, Dingke ;

Chen, Yuqi ;

Ma, Lu ;

You, Chao .

CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)

← 1 →